Last reviewed · How we verify

NCT03611543

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

Completed Results posted Last updated 21 May 2025
What this trial tests

trial testing Standard of Care Flat Paddle in Breast Cancer in 443 participants. Completed in 18 June 2018.

Timeline
20 October 2016
Primary endpoint
18 June 2018
18 June 2018

Quick facts

Lead sponsorHologic, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment443
Start date20 October 2016
Primary completion18 June 2018
Estimated completion18 June 2018
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hologic, Inc.

Who can join

25 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Subject Comfort Primary · 1 day (Day of procedure, No follow-up)

The Universal Pain Assessment Tool (UPAT) was used to assess each subject's comfort perception with each paddle (SOC and INV). The UPAT ranges from 0 to 10, where 0 represents 'no pain' and 10 'worst pain possible'.

GroupValue95% CI
INVESTIGATIONAL2.62.3 – 2.6
STANDARD OF CARE4.03.6 – 4.1
Breast Tissue Coverage Secondary · 1 Day (Day of procedure, No Follow-up)

An expert technologist evaluated the performance of the SOC and the INV paddles in 388 subjects. For each participant, the technologist answered which paddle was better at pulling in more breast tissue during imaging between SOC and INV (all subjects were imaged with both paddles during the same session). The technologist rated the paddles using a 5-point Likert scale, where -2 and -1 values mean that the SOC paddle performed better or slightly better, 0 means equal performance between paddles, and 2 and 1 mean that the INV performed better or slightly better than the SOC paddle. Note that

Rate -2 or -1 (SOC better or slightly better than INV)
GroupValue95% CI
All Enrolled Subjects69
Rate 0 ( SOC equal INV)
GroupValue95% CI
All Enrolled Subjects162
Rate 2 or 1 ( INV better or slightly better than SOC)
GroupValue95% CI
All Enrolled Subjects157
Overall Determination of Image Quality Secondary · 1 day (Day of procedure, No Follow-up)

An expert radiologist reviewed, side by side, 3D images acquired with the INV and the SOC paddles in 420 subjects. The radiologist rated the images using a 5-point Likert scale, where -2 and -1 values mean that the images acquired with the SOC paddle have better or slightly better quality, 0 means equal quality between the images, and 2 and 1 mean that the images acquired with the INV paddle have better or slightly better quality than the SOC paddle. To determine overall clinical image quality or image acceptability, the radiologist considered whether the images reviewed have fair lesion vis

Rate -2 or -1 (SOC better or slightly better than INV)
GroupValue95% CI
All Enrolled Subjects27
Rate 0 (SOC equal INV)
GroupValue95% CI
All Enrolled Subjects330
Rate 2 or 1 (INV better or slightly better than SOC)
GroupValue95% CI
All Enrolled Subjects63

Sponsor's own description

The goal of this study is to evaluate patient comfort during compression with a standard flat mammographic paddle and an investigational curved paddle. This is a study that will be performed with x-ray imaging and will be used to determine if an overall reduction in pain can be appreciated in patients without loss in image quality as compared to the current standard mammogram. Another benefit of the curved paddle may be an increase of perceivable and measurable tissue capture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Hologic, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03611543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing